Legacy Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Legacy Advisors's RGEN Position: Q1 2025 in Review
Legacy Advisors reduced its Repligen (RGEN) stake by 1.5% in Q1 2025, selling an estimated $14.3K and leaving 6,107 shares worth $777K. The position accounts for 0.08% of the portfolio, ranked #197.
Legacy Advisors first reported a position in RGEN in Q3 2022 and has held it in 11 quarters since. The position peaked at $892K in Q4 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Legacy Advisors held 6,107 shares of Repligen worth $777K as of Q1 2025.
- Legacy Advisors sold 93 Repligen shares in Q1 2025, an estimated $14.3K.
- Repligen made up 0.08% of Legacy Advisors's portfolio in Q1 2025, its #197 holding.
- Legacy Advisors first reported a position in Repligen in Q3 2022 and has held it in 11 quarters since.
- Legacy Advisors's Repligen position peaked at $892K in Q4 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.